Paradigm Therapeutics

Manufacturing · South Carolina, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

465 W Coleman Blvd Ste 202, Mount Pleasa...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Paradigm Therapeutics

Paradigm Therapeutics is a biopharmaceutical company dedicated to improving the lives of patients with life-threatening diseases through innovative therapies. Their lead product, Zorblisa, is a proprietary topical therapy aimed at treating Epidermolysis Bullosa (EB), a rare genetic disorder. The company's efforts are focused on addressing the significant therapeutic needs of EB patients, particularly in areas such as wound healing and infection management. Paradigm Therapeutics recently expanded its portfolio by acquiring a late-stage breakthrough therapy for all subtypes of EB, enhancing its commitment to patient care.Explore more
Paradigm Therapeutics's Social MediaPopular SearchesParadigm Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

Paradigm Therapeutics Org Chart

PhoneEmail
WL
United States flag for contact location.

Executive VP, Clinical Operations

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
RN
United States flag for contact location.

Executive VP Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MS
United States flag for contact location.

Head of Cns Therapy Area

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Paradigm Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Paradigm Therapeutics

Compare insights from companies similar to Paradigm Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Paradigm Therapeutics

<$5M
11-50
Private
$12.6M
-
WL
Willistine LenonExecutive VP, Clinical Operations
$6M
11-50
Private
-
2022
JC
Joshua CragoVice President, Pharmacy Operations
<$5M
11-50
Private
-
2001
OL
Olga LementaClinical Research Associate
<$5M
11-50
Private
-
2002
SX
Shi XuSenior Director
<$5M
11-50
Private
-
-
<$5M
11-50
Private
-
-
JN
Jewels NzeakoAssociate Medical Director
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Paradigm Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Paradigm Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Paradigm Therapeutics.

Paradigm Therapeutics financials insights

Gather financial insights about Paradigm Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Other Financing Round

$12.6M

See All Paradigm Therapeutics's Financials Insights

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Paradigm Therapeutics

What is Paradigm Therapeutics's official website?
Paradigm Therapeutics's official website is www.paradigmtherapeutics.com
What is Paradigm Therapeutics's Revenue?
Paradigm Therapeutics's revenue is <$5 Million
What is Paradigm Therapeutics's SIC code?
Paradigm Therapeutics's SIC: 28,283
What is Paradigm Therapeutics's NAICS code?
Paradigm Therapeutics's NAICS: 32,325
How many employees does Paradigm Therapeutics have?
Paradigm Therapeutics has 11-50 employees
What industry does Paradigm Therapeutics belong to?
Paradigm Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Paradigm Therapeutics competition?
Paradigm Therapeutics top competitors include: Sinaptica Therapeutics, ViaDerma, KangLaiTe USA, Uncommon Cures
What does Paradigm Therapeutics do?

Paradigm Therapeutics is a biopharmaceutical company dedicated to improving the lives of patients with life-threatening diseases through innovative therapies. Their lead product, Zorblisa, is a proprietary topical therapy aimed at treating Epidermolysis Bullosa (EB), a rare genetic disorder. The company's efforts are focused on addressing the signi... ficant therapeutic needs of EB patients, particularly in areas such as wound healing and infection management. Paradigm Therapeutics recently expanded its portfolio by acquiring a late-stage breakthrough therapy for all subtypes of EB, enhancing its commitment to patient care.Read More

What are Paradigm Therapeutics social media links?
Paradigm Therapeutics Linkedin page
Who invested in Paradigm Therapeutics?
Paradigm Therapeutics has 2 investors including Eshelman Ventures and Eshelman Ventures.
Is Paradigm Therapeutics a public company?
Paradigm Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Paradigm Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.